HUTCHMED (China) Ltd

NASDAQ:HCMUnited States

HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering drug discovery, development, manufacturing and regulatory functions as well as administrative activities to support research and development operations, also covering sales, marketing, manufacturing and distribution of drug developed from research and development activities. The Other Ventures segment is involved in other commercial businesses including the sales, marketing, manufacturing and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products.

Contact Information

Headquarters

48Th Floor, Cheung Kong Center 2 Queen's Road Central, Hong Kong

Phone

---

Fax

---

Executives

Executive Chairman of the Board

Chi Keung To

Chief Executive Officer, Chief Scientific Officer, Executive Director

Weiguo Su

Chief Financial Officer, Executive Director

Chig Fung Cheng

Chief Operating Officer, Executive Vice President

Karen Atkin

Executive Vice President and Chief Commercial Officer, China

Hong Chen